Advertisement

Topics

"FDAnews Announces Five Case Studies Using E2500 Approach" Drugs and Medication Database

06:56 EDT 19th October 2018 | BioPortfolio

Here are the most relevant "FDAnews Announces Five Case Studies Using E2500 Approach" Drugs and Medications that we have found in our database.

More Information about "FDAnews Announces Five Case Studies Using E2500 Approach" on BioPortfolio

We have published hundreds of FDAnews Announces Five Case Studies Using E2500 Approach news stories on BioPortfolio along with dozens of FDAnews Announces Five Case Studies Using E2500 Approach Clinical Trials and PubMed Articles about FDAnews Announces Five Case Studies Using E2500 Approach for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FDAnews Announces Five Case Studies Using E2500 Approach Companies in our database. You can also find out about relevant FDAnews Announces Five Case Studies Using E2500 Approach Drugs and Medications on this site too.

Showing "FDAnews Announces Five Case Studies Using E2500 Approach" Drugs and Medications, all 19

Possibly Relevant

Ammonia inhalants [James Alexander Corporation]

Drug Facts

Cold sore treatment [H and P Industries, Inc. dba Triad Group]

DRUG FACTS

Cold sore treatment [H and P Industries, Inc. dba Triad Group]

DRUG FACTS

Cold sore treatment [Kmart Corporation]

DRUG FACTS

Cold sore treatment [H and P Industries, Inc. dba Triad Group]

DRUG FACTS

Cold sore treatment [H and P Industries, Inc. dba Triad Group]

DRUG FACTS

Cold sore treatment [Meijer Distribution Inc]

DRUG FACTS

Cold sore treatment [McKesson]

DRUG FACTS

Cold sore treatment [Amerisource Bergen]

DRUG FACTS

Cold sore treatment [H and P Industries, Inc. dba Triad Group]

DRUG FACTS

Cold sore treatment [Cardinal Health]

DRUG FACTS

Xarelto [Janssen Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use XARELTO (rivaroxaban) safely and effectively. See full prescribing information for XARELTO. XARELTO (rivaroxaban) tablets, for oral useInitial U.S. Approval: 2011

Nicardipine hydrochloride [Sandoz Inc. ]

Rx only

Nicardipine hydrochloride [Sandoz Inc. ]

Rx only

Nicardipine hydrochloride [Emcure Pharmaceuticals Ltd.]

Rx only

Ezy-tm [Jiangxi Sencen Hygienic Products Co., Ltd.]

Drug Fact

Synapryn [Fusion Pharmaceuticals LLC]

SYNAPRYN

Tabradol [Fusion Pharmaceuticals LLC]

TABRADOL

Detrol la [PD-Rx Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use Detrol LA safely and effectively. See full prescribing information for Detrol LA.  Detrol LA (tolterodine tartrate extended release capsules)For oral administrationInitial U.S. Approval:



Advertisement
Quick Search
Advertisement
Advertisement